We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00006825
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : March 28, 2011
National Cancer Institute (NCI)
Information provided by:
New York University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2004
  Study Completion Date : No date given